---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-006796"
form_type: "8-K"
ticker: "ITGR"
cik: "0001114483"
company_name: "Integer Holdings Corp"
filed_at: "2022-10-27T23:59:59+00:00"
generated_at: "2026-06-22T23:32:48.682320+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Integer Q3 sales up 12% to $343M; GAAP net income down 27% to $16M

## Summary
- Sales increased 12% to $343M; GAAP EPS $0.48 vs $0.66 prior year; adjusted EPS $0.95 vs $1.05.
- Cardio & Vascular sales +14%; Cardiac Rhythm Management +8%; Advanced Surgical +17%; Electrochem +24%.
- 2022 outlook: GAAP sales $1.35-1.38B, adj. EBITDA $244-260M, adj. EPS $3.57-3.97; organic growth 4-6%.
- Total debt rose $111M to $939M due to Aran Biomedical acquisition for $129M; leverage ratio 3.8x.
- CEO expects 2023 revenue growth of 7-9% with margin expansion; supply chain delays to be recovered in 2023.

## SEC filing metadata
- accession: 0001171843-22-006796
- form_type: 8-K
- ticker: ITGR
- cik: 0001114483
- company_name: Integer Holdings Corp
- filed_at: 2022-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1114483/000117184322006796/0001171843-22-006796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1114483/000117184322006796/f8k_102622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-006796
- JSON: https://secwatch.observer/filing/0001171843-22-006796.json
- Plain text: https://secwatch.observer/filing/0001171843-22-006796.txt

## Key facts
- Earnings Releases
  Integer Holdings Corp reported three months ended September 30, 2022 results: revenue $343 million, net income $16 million, EPS $0.48 per share. Guidance reaffirmed.
  - Period: three months ended September 30, 2022
  - Revenue: $343 million
  - Net income: $16 million
  - EPS: $0.48 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: today announced results for the three months ended September 30, 2022. Third Quarter 2022 Highlights (compared to Third Quarter 2021, except as noted) Sales increased 12% to $343 million. GAAP net income decreased $6 million to $16 million, a decrease of 27%. Non-GAAP adjusted net income decreased $3 million to $32 million, a decrease of 9%. GAAP operating income
  evidence_url: https://www.sec.gov/Archives/edgar/data/1114483/000117184322006796/0001171843-22-006796-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.